Add-on polytherapy with antidepressants and its significance in inpatients with major depression

Ken Wada, Norihito Yamada, Takashi Hamamura, Hiroshi Suzuki, Yoshiyuki Nakano, Shigetoshi Kuroda

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Add-on polytherapy with antidepressant agents was reviewed in 42 inpatients with major depression diagnosed according to the ICD-10 criteria. Twenty-eight (67.7%) patients were treated with two or more antidepressants. The most frequent combination consisted of a tricyclic antidepressant and a non-tricyclic antidepressant. Nineteen (67.8%) patients of the polytherapy group were treated with a dosage equivalent to 150 mg/day of tricyclic antidepressant. Clinically, not every patient with major depression can tolerate the adverse side effects induced by an effective dose of a single tricyclic antidepressant. From this viewpoint, add-on polytherapy with antidepressants could be one of the treatment options, especially for such intolerant patients.

Original languageEnglish
Pages (from-to)557-562
Number of pages6
JournalPsychiatry and Clinical Neurosciences
Volume53
Issue number5
DOIs
Publication statusPublished - Oct 1999

Fingerprint

Antidepressive Agents
Inpatients
Tricyclic Antidepressive Agents
International Classification of Diseases
Therapeutics

Keywords

  • Antidepressants
  • Effective dose
  • Inpatient
  • Major depression
  • Polytherapy

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Psychiatry and Mental health
  • Neuroscience(all)

Cite this

Add-on polytherapy with antidepressants and its significance in inpatients with major depression. / Wada, Ken; Yamada, Norihito; Hamamura, Takashi; Suzuki, Hiroshi; Nakano, Yoshiyuki; Kuroda, Shigetoshi.

In: Psychiatry and Clinical Neurosciences, Vol. 53, No. 5, 10.1999, p. 557-562.

Research output: Contribution to journalArticle

Wada, Ken ; Yamada, Norihito ; Hamamura, Takashi ; Suzuki, Hiroshi ; Nakano, Yoshiyuki ; Kuroda, Shigetoshi. / Add-on polytherapy with antidepressants and its significance in inpatients with major depression. In: Psychiatry and Clinical Neurosciences. 1999 ; Vol. 53, No. 5. pp. 557-562.
@article{dfdfe337f4d94d9ca9e5d12eea5603d8,
title = "Add-on polytherapy with antidepressants and its significance in inpatients with major depression",
abstract = "Add-on polytherapy with antidepressant agents was reviewed in 42 inpatients with major depression diagnosed according to the ICD-10 criteria. Twenty-eight (67.7{\%}) patients were treated with two or more antidepressants. The most frequent combination consisted of a tricyclic antidepressant and a non-tricyclic antidepressant. Nineteen (67.8{\%}) patients of the polytherapy group were treated with a dosage equivalent to 150 mg/day of tricyclic antidepressant. Clinically, not every patient with major depression can tolerate the adverse side effects induced by an effective dose of a single tricyclic antidepressant. From this viewpoint, add-on polytherapy with antidepressants could be one of the treatment options, especially for such intolerant patients.",
keywords = "Antidepressants, Effective dose, Inpatient, Major depression, Polytherapy",
author = "Ken Wada and Norihito Yamada and Takashi Hamamura and Hiroshi Suzuki and Yoshiyuki Nakano and Shigetoshi Kuroda",
year = "1999",
month = "10",
doi = "10.1046/j.1440-1819.1999.00605.x",
language = "English",
volume = "53",
pages = "557--562",
journal = "Psychiatry and Clinical Neurosciences",
issn = "1323-1316",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Add-on polytherapy with antidepressants and its significance in inpatients with major depression

AU - Wada, Ken

AU - Yamada, Norihito

AU - Hamamura, Takashi

AU - Suzuki, Hiroshi

AU - Nakano, Yoshiyuki

AU - Kuroda, Shigetoshi

PY - 1999/10

Y1 - 1999/10

N2 - Add-on polytherapy with antidepressant agents was reviewed in 42 inpatients with major depression diagnosed according to the ICD-10 criteria. Twenty-eight (67.7%) patients were treated with two or more antidepressants. The most frequent combination consisted of a tricyclic antidepressant and a non-tricyclic antidepressant. Nineteen (67.8%) patients of the polytherapy group were treated with a dosage equivalent to 150 mg/day of tricyclic antidepressant. Clinically, not every patient with major depression can tolerate the adverse side effects induced by an effective dose of a single tricyclic antidepressant. From this viewpoint, add-on polytherapy with antidepressants could be one of the treatment options, especially for such intolerant patients.

AB - Add-on polytherapy with antidepressant agents was reviewed in 42 inpatients with major depression diagnosed according to the ICD-10 criteria. Twenty-eight (67.7%) patients were treated with two or more antidepressants. The most frequent combination consisted of a tricyclic antidepressant and a non-tricyclic antidepressant. Nineteen (67.8%) patients of the polytherapy group were treated with a dosage equivalent to 150 mg/day of tricyclic antidepressant. Clinically, not every patient with major depression can tolerate the adverse side effects induced by an effective dose of a single tricyclic antidepressant. From this viewpoint, add-on polytherapy with antidepressants could be one of the treatment options, especially for such intolerant patients.

KW - Antidepressants

KW - Effective dose

KW - Inpatient

KW - Major depression

KW - Polytherapy

UR - http://www.scopus.com/inward/record.url?scp=0032701940&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032701940&partnerID=8YFLogxK

U2 - 10.1046/j.1440-1819.1999.00605.x

DO - 10.1046/j.1440-1819.1999.00605.x

M3 - Article

VL - 53

SP - 557

EP - 562

JO - Psychiatry and Clinical Neurosciences

JF - Psychiatry and Clinical Neurosciences

SN - 1323-1316

IS - 5

ER -